tions have been proposed for histones, including microtubule stabilization by histone H1 (3), regulation of cell proliferation by histones H1 (see Ref. 4 , and references therein) and H2A.X (5), repression of microbial growth by a histone H2A fragment (6) , and stimulation of glucose uptake into adipocytes and myocytes by histone H4 (7) .
The osteogenic growth peptide (OGP), initially isolated from regenerating bone marrow, is identical to the carboxyl-terminal residues 90 -103 of histone H4 (ref. 8 and Fig. 1C ). OGP is present in micromolar concentrations in the serum of mammals, including humans (8, 9) , and is secreted by cultured cells such as NIH3T3 fibroblasts, MC3T3-E1 osteoblastic cells (10) , and ROS 17/2.8 osteosarcoma cells (Fig. 1A) . In cell culture models, OGP regulates cell proliferation and activity (8, 11) . In in vivo rodent models, OGP increases bone mass (8) , stimulates blood and bone marrow cellularity, and enhances engraftment of bone marrow transplants (12) . The amino acid sequence identity between OGP and the carboxyl-terminal region of histone H4 prompted us to test the hypothesis that OGP is derived from histone H4 gene (s) . Indeed, we demonstrate that histone H4 genes do encode OGP, and that OGP synthesis is supported by leaky ribosomal scanning through the suboptimal AUG initiator of histone H4 mRNA. His102 (Fig. 1C) is a glycine 102 to histidine mutant histone H4 (H4) gene driven by the CMV promoter. The [His 102 ]H4 fragment was prepared by polymerase chain reaction (PCR) using as template the plasmid pJA5 carrying a rat somatic H4 genomic sequence (Ref. 13 ; accession no. X13554). The forward primer, 5Ј-TCT-TCTTGCTCCATTACTGC, started 30 nucleotides downstream of the TATA box (37 nucleotides upstream of the ATG initiator). The reverse primer, 5Ј-GAGggatCCGGCTCAGCCGtgGAAGCC, contained a CC 3 tg mutation at codon 102 and a BamHI site (substituted nucleotides are in lowercase) starting 4 base pairs downstream of the stop codon (bold). The PCR product was digested with BamHI and cloned between the PvuII and BamHI sites of the mammalian expression vector pCEP4 (Invitrogen, San Diego, CA).
MATERIALS AND METHODS

Constructs-pCMVH4
Plasmids containing H4-CAT fusion genes were constructed via an intermediate construct, pSVdCAT, derived from pSV2CAT (14) . In pSVdCAT, a fragment between the unique SfiI site (juxtaposed the first transcription start site) and the CAT ATG initiation codon, is replaced by 17 base pairs containing two unique restriction sites, for EcoRV and XbaI. The sequence of pSVdCAT in the fusion area downstream of the SV40 promoter is CGAGGCCGGATATCTAAGGAAGCTAATCTAGAG-AAA (original pSV2CAT sequences in italics, newly introduced restriction sites underlined, CAT gene codons 2 and 3 in bold). The SV40-H4-CAT plasmids (Figs. 2A and 3A) were then constructed by inserting H4-derived coding sequences between the EcoRV and XbaI sites of pSVdCAT. In each case the insert was obtained by PCR with reverse primers (containing XbaI sites) and forward primers as depicted below, using as templates genomic clones of either a rat somatic H4 (13) or the human H4FO108 (15) histone gene. The PCR products were digested with XbaI and inserted into pSVdCAT.
The H4-CAT coding sequences inserted in pSVdCAT either contained full-length H4 sequences (pSVrH4CAT and pSVFO108CAT; Fig. 2A ) or were truncated downstream of H4 codon 86 (constructs of the pSVrH4 ⌬87-103 CAT type). In the former case, the in-frame H4-CAT fusion is via a CTA leucine codon, which replaces the H4 stop codon and is followed by the GAG codon encoding glutamate 2 of CAT. In the latter case, a CTA leucine codon is introduced between the H4 GAT codon encoding aspartate 86 and the CAT gene GAG codon encoding glutamate 2. Forward primers used to generate the H4 inserts started 34 base pairs downstream of the H4 TATA box. They were 5Ј-aTCTTCT-TGCTCCATTACTGC for pSVrH4CAT; 5Ј-AtCTGTCTATCGGGCTC-CAGC for pSVFO108CAT; 5Ј-TCTTCTTGCTCCATTACTGC for pSVrH4 ⌬87-103 CAT and pSVrH4 ⌬87-103 CAT(A/T); 5Ј-aTCTTCTTGCTCCATTACTGCTCTACTAGGtTGTCTGG for pSVrH4 ⌬87-103 CAT(T/A) and pSVrH4 ⌬87-103 CAT(T/T); and 5Ј-aTCTTCTTGCTCCATTACTGCTCTgCcgccaccATGgCTGGACGAGGG for pSVrH4 ⌬87-103 CAT(A!/ A); lowercase fonts indicate deviations from the wild type sequence, introduced to either restore an EcoRV site at the fusion point with pSVdCAT, to mutate the ATG 1 initiator to tTG, or to optimize the sequence around ATG 1 for efficient translation initiation. Reverse primers were 5Ј-ACACCGtCTagaCCGCCGAAGCCATAGAGCG for pSVrH4CAT; 5Ј-AGCGGCtCtagaCCTCCGAAGCCGTAGAGGG for pSVFO108CAT; 5Ј-GAGCGCGTACtCtAgaTCCATAGCCGTG for pSVrH4 ⌬87-103 CAT, pSVrH4 ⌬87-103 CAT (T/A), and pSVrH4 ⌬87-103 CAT (A!/A); and 5Ј-GAGCGCGTACtCtAgaTCCAaAGCCGTG for pSVrH4 ⌬87-103 CAT(A/T) and pSVrH4 ⌬87-103 CAT(T/T); lowercase fonts indicate mutations introduced to generate XbaI sites, or to mutate ATG 85 to tTG (CAa on the bottom strand). Finally, pSVrH4CAT(A!/A) and pSVrH4CAT(T/A) ( Cell Culture and Transfections-ROS 17/2.8 rat osteosarcoma cells (16) were maintained in Ham's F-12 medium supplemented with 5% fetal bovine serum (FBS). NMuMG normal mouse mammary gland cells (17) were maintained in DMEM containing 10% FBS and 10 g/ml insulin. DU 145 human prostatic carcinoma cells (18) were maintained in DMEM/RPMI 1640 (1:1) and 10% FBS. BALB/3T3 mouse embryonic cells (19) were maintained in DMEM supplemented with 10% calf serum, 4 mM L-glutamine, 4.5 g/liter glucose, and 1 mM sodium pyruvate. CV-1 African green monkey kidney cells (20) were maintained in DMEM supplemented with 10% FBS. Media were purchased from Life Technologies, Inc., and serum was from Omega Scientific Inc., Tarzana, CA. All transfections were performed with 20 g of DNA in 100-mm culture dishes. Stable and transient transfection of ROS 17/2.8 cells employed the calcium phosphate (21) or the DEAE-dextran methods, respectively, exactly as in Ref. 22 . In some experiments, ROS 17/2.8 cells were also transiently transfected using the LipofectAMINE TM reagent (Life Technologies, Inc.) according to the manufacturer's recommendations, yielding essentially the same results. The Lipofect-AMINE TM reagent was also used for transient transfection of all the other cell lines.
Northern Blot Analysis-Total RNA was extracted from proliferating ROS 17/2.8 cell cultures with guanidinium thiocyanate-phenol-chloroform (23) using the Trizol reagent from Life Technologies, Inc. Samples (25 g) were electrophoresed in 1% agarose gels and blotted onto a Nylon-Nϩ membrane (Amersham Pharmacia Biotech). Oligonucleotide probes corresponded to the OGP amino acid sequence (8) , and the codons were selected based on either a cloned H4 gene (Ref. 13 ; 5Ј-GCGCTCAAGCGCCAGGGCCGCACGCTCTATGGCTTCGGC) or codon usage frequency (Ref. 24; 5Ј-GCCGCCAAAGCCATACAGGGTC-CGGCCCTGCCGCTTCAGGGC). The oligonucleotides were labeled by tailing with [␣-32 P]dATP using terminal deoxytransferase (Roche Molecular Biochemicals) according to the manufacturer's protocol. Prehybridization (6 h, 50°C) and hybridization (12 h, 50°C) were in 1ϫ SSC solution containing 2% SDS, 2ϫ Denhardt's solution, 1% nonfat dry milk, and 200 g/ml salmon sperm DNA. The final wash was carried out at 50°C with 0.1ϫ SCC and 0.2% SDS.
Western Blot Analysis-Cells were harvested in ice-cold phosphatebuffered saline, pelleted, and lysed in 60 mM Tris-HCl buffer containing 2% SDS. Protein concentration in cell lysates was determined using a micro-BCA protein assay kit 23235 (Pierce), and samples supplemented with 2-mercaptoethanol (2%, v/v) were subjected to SDS-polyacrylamide gel electrophoresis (12% gel). The resolved proteins were transferred to Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech) and CAT-immunoreactive proteins visualized with anti-CAT antibodies (5Prime 3 3Prime, Boulder, CO; 1:300 dilution) and antirabbit IgG-conjugated horse radish peroxidase (Santa Cruz Biotechnology, Santa Cruz, CA) using the ECL immunodetection kit (Amersham Pharmacia Biotech).
Peptide Synthesis and Purification-Synthetic peptides were prepared by the standard solid phase methodology (25) . Peptides in conditioned medium or in cell lysate were purified by boiling, size exclusion, and reverse phase HPLC as described previously (9) .
ELISA-The presence of OGP, [His 13 ]OGP, and immunoreactive products was determined in HPLC fractions by ELISA (10) using corresponding polyclonal antibodies generated in rabbits challenged with maleimido-modified keyhole limpet hemocyanin conjugated with either synthetic peptide (8) .
[His 18 ]PreOGP Proteolysis-ROS 17/2.8 cells were rinsed and harvested in phosphate-buffered saline. Whole cell extract was prepared by resuspending the cell pellet (ϳ2 ϫ 10 6 cells) in 0.5 ml of 25 mM Tris-HCl buffer containing 0.25% Triton X-100, followed by homogenization (20 strokes with a tight fitting pestle) and sonication (four intervals of 10 s). Synthetic [His 18 ]PreOGP was incubated with ROS 17/2.8 cell extracts for 1 h at 37°C. Peptides were isolated from the reaction mixture by boiling, size exclusion, and reverse phase HPLC and the eluted fractions subjected to ELISA using anti-[His 13 ]OGP antibodies.
RESULTS
Histone H4 Gene Expresses OGP-Although OGP, present abundantly in the serum and in cell culture media, is identical to the H4 carboxyl terminus, it was not known whether the two polypeptides, H4 and OGP, could be synthesized from the same template. The possible occurrence of a non-H4 mRNA that encodes OGP was addressed by Northern analysis of ROS 17/2.8 cells, which we had confirmed secrete OGP (Fig. 1A) . The probe was a radiolabeled oligonucleotide complementary to the codons that most likely encode the reported OGP amino acid sequence (8) based on codon usage frequency (24) . A parallel RNA blot was probed with a radiolabeled oligonucleotide complementary to the OGP-respective sequence of a known rat somatic H4 gene (Ref. 13 ; accession no. X13554). As shown in Fig. 1B , the "common usage" OGP probe hybridized with a single-size short transcript(s), which co-migrated with H4 mRNA. Thus, OGP is likely encoded exclusively by H4 mRNA(s), although the possibility of OGP translation from a transcript similar in size to, yet distinct from, H4 mRNA cannot be excluded.
To directly demonstrate the synthesis of OGP from an H4 mRNA, we introduced a histidine 102-tagged H4 gene into cells and assayed medium conditioned by these cells for the corresponding tagged OGP. ROS 17/2.8 cells were stably transfected with pCMVH4 His102 (Fig. 1C) , containing a CMV-driven rat somatic H4 gene (13) , in which the GGC glycine 102 codon was replaced by CAC, encoding histidine. If OGP is produced from this H4 gene, then the transfected cells may secrete an OGP molecule with a glycine to histidine mutation at position 13 ( 13 ]OGP was detected in medium conditioned by nontransfected ROS 17/2.8 cells (data not shown). Thus, a histidine-tagged H4 coding sequence gave rise to a secreted histidine-containing OGP mutant in transfected ROS 17/2.8 cells, suggesting that this and perhaps other H4 genes encode both H4, a component of the eukaryotic DNA packaging apparatus, and OGP, a secreted regulatory polypeptide.
Production of Long and Short CAT Proteins from H4-CAT
Fusion Genes-To further investigate the production of both H4 and OGP from H4 genes we constructed two CAT-tagged H4 genes ( Fig. 2A) , in which the CAT sequence, starting at its second codon, was fused in frame to the H4 coding sequence of either the rat somatic H4 gene used in Fig. 1 , or to the coding sequence of a human H4 gene, H4FO108 (Ref. 15 ; accession no. M16707). Each of these constructs, pSVrH4CAT and pSVH4FO108CAT, encodes an H4-CAT fusion protein of ϳ35 kDa, comprising ϳ10-kDa and ϳ25-kDa H4 and CAT moieties, respectively. However, if the mechanism of OGP synthesis from H4 genes ( Fig. 1 ) is not interfered with by the CAT tag, then an additional, shorter CAT derivative of ϳ26 kDa should be produced from each of these constructs. The two plasmids were each transiently transfected into ROS17/2.8 cells and whole cell extracts subjected to Western analysis using anti-CAT antibodies. As shown in Fig. 2B for both of these constructs (lanes 3 and 4), the 35-kDa band representing the full-length ]OGP peak was observed in two independent experiments, but not in conditioned medium from nontransfected cells.
FIG. 1. OGP is a product of histone H4 gene(s).
A, accumulation of immunoreactive OGP (irOGP) in culture medium of ROS 17/2.8 cells. Cells were cultured and irOGP determined as reported (10) . Data represent mean Ϯ S.D. obtained in triplicate culture wells at each time point. B, Northern blot analysis of ROS 17/2.8 cells with an OGP common usage codon probe. Total RNA was extracted from proliferating ROS 17/2.8 cells and two identical samples subjected to Northern blot analysis. Lane 1, the membrane was probed with an oligonucleotide complementary to a hypothetical OGP mRNA predicted from codon usage frequency (24) ; lane 2, a parallel membrane was probed with an oligonucleotide corresponding to the OGP domain of a rat somatic H4 gene (13) . Bars represent location of the 28 and 18 S ribosomal RNA. C, schematic illustration of H4 gene and pCMVH4 His102 . Histone H4 gene is shown at the top with OGP represented by a shaded box and transcription start site indicated by horizontal arrow. Codons encoding H4 and OGP NH 2 and COOH termini are numbered (arrowheads). fusion protein (double arrowhead) is accompanied by a lower molecular mass CAT-immunoreactive doublet with apparent molecular masses of 25.7 kDa (arrowhead) and 24.8 kDa (small arrow). The 25.7-kDa band is consistent with the production of an OGP-CAT fusion protein from the H4-CAT genes. The 24.8-kDa CAT species, which co-migrates with a CAT protein expressed from pSV2CAT (lane 1), may represent a proteolytic product of the 35-and/or 25.7-kDa protein (see below). These results are consistent with the conclusion from Fig. 1 , that the rat somatic X13554 H4 gene encodes both H4 and OGP, and suggest that this may be shared by other H4 genes.
Production of Short CAT from H4-CAT Fusion Gene Does Not Require Proteolytic Sites at the H4 COOH Terminus-Production of both OGP (Fig. 1D ) and the short CAT proteins (Fig. 2 ) could occur via a chymotrypsin-like cleavage of H4 at the Tyr 89 -Ala 90 site (Fig. 1C) . To examine this possibility, we prepared a pSVrH4CAT internal deletion construct, pSVrH4 ⌬87-103 CAT (abbreviated A/A; Fig. 3A) , in which the histone codons 87-103, containing this proteolytic site, are missing. The deleted sequence included an additional chymotrypsin-like cleavage site, between Tyr 99 and Gly 100 (Fig. 1A) , which could have also contributed to production of the short CAT forms (Fig. 2B) , but it did not include the ATG 85 codon (see below). Western analysis of ROS 17/2.8 cells transfected with the A/A construct (Fig. 3B, lane 3) clearly indicates expression of two CAT species (ϳ35 and ϳ25 kDa), similar to those observed with constructs containing full-length H4 sequences (Fig. 2B) . This result suggests that the generation of alternative CAT products observed in cells transfected with H4-CAT fusion genes does not require proteolytic cleavage anywhere between residues 87 and 103 of the H4-CAT fusion protein.
De Novo Production of Short CAT from H4-CAT Fusion Gene-Production of OGP from H4 genes could occur de novo by translational initiation at the AUG 85 codon (Fig. 1C) , followed by removal of five amino-terminal residues. The feasibility of such de novo synthesis was examined by constructing pSVrH4 ⌬87-103 CAT(T/A), which differs from pSVrH4 ⌬87-103 CAT in that the H4 ATG initiator is mutated to TTG (Fig. 3A) . As expected, cells transfected with this construct (abbreviated T/A) do not express the ϳ35-kDa H4-CAT fusion protein (Fig. 3B, lane 5) . However, the ϳ25-kDa CAT form is fully retained, indicating its production in the absence of the long CAT form, likely via translational initiation at AUG 85 . Enhanced expression of the short CAT from the T/A as compared with the A/A construct (Fig. 3B) , confirmed with three independent pairs of plasmid preparations, may be explained by more rapid ribosomal scanning through the otherwise translated H4 codons 1-84.
ATG 85 Is Required for Production of Short CAT from H4-CAT Fusion Gene-To directly address involvement of the ATG 85 codon in synthesis of the short CAT form, ROS 17/2.8 cells were transfected with pSVrH4 ⌬87-103 CAT(A/T), which differs from pSVrH4 ⌬87-103 CAT in that ATG 85 is substituted by TTG. As shown in Fig. 3B (lane 4) , this mutation specifically abrogated synthesis of the short CAT form, suggesting that alternative translation is indeed involved in the production of the ϳ25-kDa protein. Finally, neither the long nor the short CAT forms were detected in cells transfected with pSVrH4 ⌬87-103CAT(T/T) (Fig. 3B, lane 6 (Table I) , the initiation codon of the rat somatic X13554 H4 gene used in this study is followed by a thymidine. Because guanine in this position is the optimal nucleotide for high fidelity translational initiation (26, 27) , we hypothesized that translational initiation at AUG 85 occurs when ribosomal scanning fails to recognize the AUG 1 codon as a translation start site (26, 27) . To test this hypothesis, we constructed pSVrH4 ⌬87-103 CAT(A!/A) (abbreviated A!/A) in which nucleotides flanking the ATG 1 codon are substituted from ACTAGGAAGATGT to GCCGCCACCATGG. The latter sequence provides the most optimal environment for translational initiation (27) . As shown in Fig. 3C , pSVrH4 ⌬87-103CAT(A!/A) transfected into ROS17/2.8 cells gave rise to an increased level of the ϳ35-kDa CAT protein, accompanied by a decrease in the ϳ25-kDa CAT form. Thus, optimization of the rat somatic H4 sequence around ATG 1 to enhance translational initiation inhibited utilization of the alternative AUG 85 initiator, suggesting that translational initiation at AUG 85 is attributable primarily to leaky ribosomal scanning through AUG 1 . 
Conversion of PreOGP (H4-(85-103)) to OGP (H4-(90 -103))-Translational
, or both (indicated by A) are mutated to TTG (indicated by T).
These three constructs are abbreviated as A/T, T/A and T/T, respectively. In pSVrH4 ⌬87-103 CAT(A!/A), the nucleotide sequence surrounding ATG 1 was altered to optimize translational initiation. Box designation is as in Fig. 2A . (Fig. 4B) . Interestingly, this pentapeptide, known as historphin, has opiate-like and chronotropic effects in heart muscle and intestine (28) . Thus, ROS 17/2.8 cells exhibit proteolytic activities capable of converting PreOGP mainly to OGP, and, to a lesser extent, to historphin (OGP- (10 -14) ).
B, Western analysis of ROS 17/2.8 cells transiently transfected with an unrelated plasmid (lane 1), pSV2CAT (14) (lane 2), A/A (lane 3), A/T (lane 4), T/A (lane 5), or T/T (lane 6). CAT immunodetection was performed as in Fig. 2B. C, same as B, with A!/A (lane 1), A/A (lane 2), and an unrelated plasmid (lane 3). Single and double arrowheads indicate CAT-immunoreactive proteins of
Leaky Ribosomal Scanning of H4-CAT mRNA and Proteolysis of H4-CAT Protein Give Rise to Different Short CAT Products-Deletion of the PreOGP sequence from the H4-CAT fusion gene did not significantly lessen the amount of the short CAT product relative to the full-length H4-CAT fusion protein (compare the 25.7-kDa product of pSVrH4CAT in Fig. 2B to the short CAT product of pSVrH4 ⌬87-103 CAT in Fig. 3B ). This observation suggests that in the context of full-length H4, the proteolytic site involved in the conversion of PreOGP to OGP (Fig. 4) is inaccessible to proteolytic cleavage. If the site was accessible, then the PreOGP-containing construct, pSVrH4CAT (Fig. 2B) , would have yielded a higher short/long CAT ratio, because generation of the short CAT from this construct would have been the consequence of both leaky ribosomal scanning (same as in pSVrH4 ⌬87-103 CAT) and proteolytic processing of the long CAT. To further test this hypothesis, we constructed pSVrH4CAT(A!/A) (Fig. 5A) , containing a full-length H4-CAT gene, in which the nucleotide sequence surrounding ATG 1 was altered as in pSVrH4 ⌬87-103 CAT(A!/A) (Fig. 3) to minimize leaky ribosomal scanning. As shown in Fig.  5B , the optimization of ATG 1 resulted in obliteration of the 25.7-kDa CAT-immunoreactive band (single arrowhead) in transfected ROS 17/2.8 cells, suggesting that this protein (probably OGP-CAT) is synthesized primarily via leaky ribosomal scanning, and not by proteolysis of full-length H4-CAT. Thus, the CAT-tagged H4 protein apparently escaped the proteolytic activity demonstrated in Fig. 4 using PreOGP as substrate.
Unlike the 25.7-kDa OGP-CAT protein, the 24.8-kDa CAT species (Fig. 2B, small arrow) was resistant to sealing of the leaky ATG 1 . Its retention in cells transfected with pSVrH4CAT(A!/A) (Fig. 5, lane 2) suggests a biosynthetic pathway distinct from that of the 25.7-kDa OGP-CAT, perhaps proteolysis of full-length H4-CAT. To test this possibility, we constructed and transfected cells with pSVrH4CAT(T/A), containing a full-length H4-CAT gene in which ATG 1 had been mutated to TTG. As shown in Fig. 5 (lane 3) , the expected 85 of representative H4 genes The nucleotide sequence flanking the first and 85th codons of representative histone H4 genes are shown for some higher and lower eukaryotic organisms. Horizontal arrows indicate the two genes used in the present study. ATG 1 and ATG 85 are in bold, as are nucleotides at positions Ϫ3 and ϩ4 relative to each ATG (the A being ϩ1). Nucleotides at these positions that do not comply with the (A/G) NNATGG consensus for translational initiation (26, 27) ACA AAA ATG GCC ACT GCT ATG GAC
Oxitricha nova M24411
AAC ACA ATG GCC ACC GCC cTc GAC
Stylonichia lemnae X16018
ATT AAA ATG GCC ACT GCT cTc GAC
X16019
AAT cAA ATG GCC ACC GCT cTc GAT
Yeast
S. pombe X05222
CTT AAC ATG tCT ACT tCT tTG GAC
S. cerevisiae Z35878
TAA AAT ATG tCC ACT tCT tTG GAT
S. carlsbergensis K03154
AAA ATA ATG tCC ACT tCT tTG GAT
Filamentous fungi Aspergillus X55549
ATC AAC ATG tCT ACA tCT cTc GAC
Slime mold P. polycephalum X15141
ATA cAC ATG tCT ACA GCA ATG GAT absence of full-length H4-CAT in these cells is accompanied by specific loss of most, although clearly not all, of the 24.8-kDa CAT form, suggesting that it was indeed generated primarily from H4-CAT by proteolysis. The residual 24.8-kDa CAT form suggests that it may also be produced, to a limited extent, by proteolysis of the 25.7-kDa CAT form. The pathways contributing to production of the 25.7-kDa (OGP-CAT?) and the 24.8-kDa (OGP-(10 -14)-CAT?) proteins are schematically illustrated in Fig. 5C . Cell Type-dependent Ratio between "Long CAT" and "Short CAT" Produced from H4-CAT Fusion Gene-Because H4 is expressed ubiquitously, it was of interest to assess whether translational initiation at AUG 85 would occur in any cell versus the exclusive utilization of the AUG 1 codon by selected cell types. pSVrH4 ⌬87-103 CAT (Fig. 2) was transfected into five randomly selected cell lines, and the ratio between the long and the short CAT forms evaluated by Western blot analysis using anti-CAT antibodies. As shown in Fig. 6 , all the cells tested expressed both the long and the short CAT species. ROS 17/2.8 and two other cell lines, DU 145 human prostatic carcinoma cells and CV-1 monkey kidney cells, expressed the full-length H4-CAT protein at levels that are severalfold higher than the expression of the short CAT protein. The short CAT was expressed at levels equal to or higher than the long CAT in NMuNG mouse mammary gland cells and BALB/3T3 mouse embryonic cells, respectively. These results suggest that the dual function of H4 mRNA leading to the biosynthesis of distinct products, is shared by many cells, but the ratio between the two products, H4 and PreOGP, depends significantly on the cell type. The mechanisms responsible for this cell type-specific regulation remain to be explored. DISCUSSION OGP is a regulator of cell growth and activity identical to the carboxyl terminus of H4 (H4-(90 -103) ). Similar to all other histone genes, the H4 genes are present in higher eukaryotes in multiple copies and they typically lack introns (1, 29) . All mammalian H4 genes encode the same polypeptide. Significant diversity observed in the third position of most codons as well as outside the protein-coding sequence is assumed to ensure expression in a variety of cells under broad physiological conditions. OGP could be a de novo translational product of any of (Fig. 1) . Furthermore, we altered a rat somatic H4 gene (X13554) at codon 102, and showed that this bona fide H4 gene gave rise to the anticipated OGP mutant in transfected cells (Fig. 1) . Since selection of the rat somatic H4 gene, as well as the human H4FO108 gene (see below) was random, our results suggest that OGP is produced from these and probably other H4 genes.
H4-derived constructs, based on either the rat somatic (X13554) or the human H4 FO108 (M16707) genes, in which the H4 coding sequences were fused in frame to the bacterial CAT gene lacking its ATG initiation codon, gave rise to both long and short CAT-containing proteins (Fig. 2) , consistent with the production of OGP from H4 genes. By deletion and point mutations of the rat H4-CAT fusion gene, it was demonstrated that production of the long and short proteins depends on ATG 1 and ATG 85 , respectively, suggesting that translation can start at either of these methionine codons (Fig. 3) . In addition, we showed that the predicted translation product of the downstream initiation (H4-(85-103)), which we have designated PreOGP, is processed to OGP by a ROS 17/2.8 cell extract (Fig. 4) . It therefore appears that the H4 mRNA is translated simultaneously to both H4 protein and PreOGP. The latter is then converted to OGP.
The PreOGP-to-OGP pathway may be mediated by either limited exopeptidase activity or a specific endopeptidase. Either way, a CAT-tagged H4 protein did not serve as a substrate for this activity in transfected cells (Fig. 5) , possibly reflecting sequestration of the proteolytic site when residing within a full-length H4 protein sequence. As opposed to H4 proteolysis, de novo synthesis of OGP via alternative translation of H4 mRNA, as suggested by the present study, facilitates the production and secretion of OGP independently of H4 protein synthesis. Furthermore, OGP synthesis by alternative translation avoids production of a truncated H4 protein (amino acids 1-89), which may be undesirable to the cell. Although irrelevant to OGP biosynthesis, our experiments with CAT-tagged H4 genes also disclosed proteolysis of the H4 peptide sequence at a site within the OGP domain (Fig. 5) . This activity may be related to the limited production of OGP-(10 -14) from PreOGP and/or OGP (Fig. 4) . This proteolytic activity seems to favor the full-length H4 over PreOGP or OGP as substrate (Fig. 5) . Thus, we propose three previously unidentified processes in H4 gene expression: (i) alternative translational initiation at AUG 85 , giving rise to PreOGP; (ii) proteolysis between Tyr 5 and Ala 6 of the PreOGP, thus yielding OGP; and (iii) proteolysis at a further COOH-terminal site, with full-length H4 as the preferred substrate. Possible roles for the latter proteolytic activity include synthesis of OGP-(10 -14) and, perhaps, regulation of H4 stability and availability for DNA packaging.
Translational initiation at an AUG codon that is not the first following the transcription start site is uncommon for genes encoding structural proteins but rather frequently observed in genes encoding regulatory polypeptides such as cytokines, receptors, protein kinases, transcription factors, and growth factors (reviewed in Ref. 30) . Unlike viral genes, downstream translational initiation of cellular genes usually reflects the presence of an mRNA molecule which starts 3Ј of the first ATG (reviewed in Ref. 30 ). However, translational initiation at a downstream AUG codon can also be mediated by internal ribosome entry, which has been demonstrated initially in viral and more recently in cellular genes (see Ref. 31 , and references therein). Finally, when the first AUG is weak due to primary sequence context, length, or structure of flanking sequences, initiation at such a site may be "leaky" leading to alternative utilization of a downstream AUG (reviewed in Ref. 30 ). Translational initiation at AUG 85 of H4 mRNAs seems to be mediated primarily by leaky ribosomal scanning through the imperfect sequence context of the AUG 1 codon, as evidenced by the inhibition of downstream translational initiation observed following optimization of the suboptimal AUG 1 (Figs. 2C and 5 ). Although alternative translation via a leaky ribosomal scanning is not unprecedented (30) , the synthesis of H4 protein and OGP from H4 mRNA is striking in that the two products apparently have diverse functions.
Fidelity of ATG initiators is primarily determined by the nucleotides occupying positions Ϫ3 and ϩ4 relative to the A of the ATG, defined as ϩ1. Optimally, these nucleotides should be a purine and a guanine, respectively. Indeed, at least one of them is found in most cellular mRNAs (32) . All higher eukaryotic H4 genes known to us, from both animals and plants, have a purine at position Ϫ3. However, position ϩ4 is usually occupied by a thymidine, or more rarely by an adenine, but never by a guanine (Table I) . Although the combination of a purine at Ϫ3 and a thymidine at ϩ4 is still rather efficient in supporting translational initiation, the deviation from the optimal sequence is sufficient to cause some leaky ribosomal scanning, thereby allowing alternative translational initiation at a second AUG (26) . Thus, based on sequence analysis, leaky ribosomal scanning through AUG 1 , demonstrated in the present study for one randomly selected H4 gene, may be a common feature of many, if not, all H4 genes in higher eukaryotes, animals and plants alike. Leaky scanning may be further enhanced in atypical H4 genes with short leaders (33) , such as the mouse clone 12 H4 gene (Ref. 34 ; accession no. X13235). In addition, utilization of the AUG 85 codon to initiate translation from any given H4 mRNA may vary as a function of the cell type (Fig. 6) and/or the physiological conditions.
Our results suggest that ATG 85 of the rat X13554 H4 gene is utilized as an alternative translational initiator to the suboptimally flanked AUG 1 codon. AUG 85 itself resides within an optimal context for translational initiation, not only in this specific gene, but almost in every eukaryotic H4 gene (Table I) . Thus, the combination of a suboptimal AUG 1 and an optimal ATG 85 appears to be a hallmark of higher eukaryotic H4 genes, lending support to the hypothesis that OGP synthesis by alternative translation of H4 genes occurs in many eukaryotic organisms and may have an important evolutionary conserved role(s). Interestingly, the 85th residue of Styela plicata, as well as most lower eukaryotic H4 genes, is a leucine ( Table I) , demonstrating that a methionine in this position is not imposed by structural requirements for DNA packaging. It is tempting to speculate that the selection of H4-AUG 85 by higher eukaryotes is related to mechanisms in these organisms, versus others (35) that allow leaky ribosomal scanning through im- perfect 5Ј proximal initiators. That OGP is ubiquitously expressed in higher eukaryotic cells is suggested not only by sequence analysis of H4 genes, but also by the identification of OGP in conditioned medium of all cell lines thus far tested: MC3T3-E1 osteoblasts, NIH3T3 fibroblasts (10) and ROS 17/ 2.8 osteosarcoma cells (this paper). This conclusion is further supported by the demonstration of long and short CAT forms produced from an H4-CAT fusion gene in five randomly selected cell types from different species (Fig. 6) . Still, the variation in the long/short CAT ratio exhibited by these cells may suggest preferential expression of OGP by certain cell types. In terms of biological activity, however, OGP production is probably just one component in a complex regulatory system, where additional factors, such as receptors for OGP and their connections with intracellular signaling networks, are most likely involved in determining the OGP target cell selectivity and the nature of the cellular response.
In summary, as suggested by sequence analysis of eukaryotic H4 genes, the present study demonstrates some leaky ribosomal scanning through AUG 1 of H4 mRNA, resulting in alternative translational initiation at AUG 85 .The predicted alternative translation product, H4-(85-103) has been designated PreOGP, as it is proteolytically processed to OGP (e.g. H4-(90 -103)), a circulating peptide that regulates cell growth and activity. This biosynthetic mechanism, apparently operative in many, if not all, eukaryotic cycling cells, may play a crucial role in the previously reported positive feedback circuit of OGP, which controls cell proliferation (10, 12) , as well as in the linkage between cell growth and differentiation.
